Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia

June 1, 2026 updated by: Hadeer Ali Darder, Sohag University
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.

Primary outcome:

• Follow up postoprative pain.

Secondary outcome:

• Requirment of analgesic drugs either (opoid or non opoid) postoprative.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Sohag, Egypt, 82516
        • sohag University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • • Age between ≥ 18 years

    • Both sexes.
    • American Society of Anesthesiologists (ASA) Physical Status I-III
    • Undergoing elective unilateral hip surgeries under spinal anesthesia
    • Patients with body mass index (BMI) < 35 kg/m²

Exclusion Criteria:

  • • Patient refusal

    • Known allergy to local anesthetics
    • Infection at the site of block
    • Coagulopathy or bleeding disorders
    • Cognitive impairment affecting pain assessment
    • Chronic opioid use
    • Neuromuscular disorders as patients with stroke.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: group A lumber electrospine plane block
20ml of 0.25% bupivacaine will be injected into the interfascial plane between the erector spinae muscle and L5 transverse process.
Drug: 0.25% bupivacaine
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia
Other Names:
  • 0.25% isobaric bupivacaine
Active Comparator: group B fascia iliaca plane block
a total of 20 mL of 0.25% bupivacaine will be slowly injected in fascia iliaca
Drug: 0.25% bupivacaine
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia
Other Names:
  • 0.25% isobaric bupivacaine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
follow up postoperative pain by Visual Analogue Scale (VAS)score
Time Frame: follow up postoperative pain in 24 hours
follow up postoperative pain every 2hours
follow up postoperative pain in 24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Requirment of analgesic drugs either (opoid or non opoid) postoprative by Viscual Analogue Scale (VAS) Score
Time Frame: Requirment of analgesic drugs either (opoid or non opoid) postoprative. in 24hours
Requirment of analgesic drugs either (opoid or non opoid) postoprative.every 2hours
Requirment of analgesic drugs either (opoid or non opoid) postoprative. in 24hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 20, 2026

Primary Completion (Estimated)

November 28, 2026

Study Completion (Estimated)

November 28, 2026

Study Registration Dates

First Submitted

March 9, 2026

First Submitted That Met QC Criteria

June 1, 2026

First Posted (Actual)

June 8, 2026

Study Record Updates

Last Update Posted (Actual)

June 8, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Erector Spinae Plane Block

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post op Pain in Hip Surgeries

Clinical Trials on 0.25% bupivacaine

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe